Navigation Links
Anavex appoints Dr. Dimitri Goundis to lead Clinical Development
Date:4/16/2008

erapeutic areas including Rocaltrol(R) in osteoporosis, Aurorix(R) in anxiety disorders and Alcar(R) in diabetic peripheral neuropathy. He holds a B.Sc. (Honors) in chemistry and biochemistry from the University of London, a Ph.D. in biochemistry from Oxford University and a Certificate in Investment Management from the London Business School.

About Anavex Life Sciences Corp.

Anavex Life Sciences Corp. (http://www.anavex.com) is an emerging biopharmaceutical company engaged in the discovery and development of novel drug targets for the treatment of cancer and neurological diseases. The company's proprietary SIGMACEPTOR(TM) Discovery Platform involves the rational drug design of compounds that fulfill specific criteria based on unmet market needs and new scientific advances. Selected drug candidates demonstrate high, non-exclusive affinity for sigma receptors, which are involved in the modulation of multiple cellular biochemical signaling pathways.

ANAVEX's SIGMACEPTOR(TM)-N program involves the development of novel and original drug candidates, targeting neurological and neurodegenerative diseases (including Alzheimer's disease, epilepsy, depression). The company's lead drug candidates exhibit high affinity for sigma receptors with strong evidence for anti-amnesic, neuroprotective, anti-apoptotic, anti-oxidative, anti-inflammatory, anti-convulsive, anti-depressant and anxiolytic properties.

ANAVEX SIGMACEPTOR(TM)-C program involves the development of novel and original drug candidates targeting cancer. The company's lead drug candidates exhibit high affinity for sigma receptors with strong evidence for selective pro-apoptotic, anti-metastatic and low toxicity properties in various types of solid cancers such as colon, prostate, breast and lung.

Forward-Looking Statements

Statements in this press release that are not strictly historical in nature are forward-looking statements
'/>"/>

SOURCE Anavex Life Sciences Corp.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Anavex 7-1037 reduces rate of cancer tumor growth 69% in pre-clinical studies, compared to currently marketed drug Dacarbazine showing no measurable activity
2. Anavex strengthens Board of Directors
3. Anavex advances drug candidate for treatment of Alzheimers disease
4. Phytomedics Inc. Appoints Dr. Laurie Smaldone Alsup, MD., as President and Chief Executive Officer
5. Metabolex Appoints Donald Hill as Chief Financial Officer
6. Biopure Appoints New Independent Auditor
7. Indivumed Appoints Annette Kassen as Vice President Clinical Research
8. ADVENTRX Appoints Vice President of Manufacturing
9. Egenix, Inc. Appoints Dr. Daniel Petrylak Chairman of Scientific Advisory Board
10. NanoLogix Inc. Provides Financial Update, Appoints Bert Pharis as New Director
11. Observant LLC Appoints Two New Directors to the Senior Management Team
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2014)... July 21, 2014 ResearchMoz ... USA Cancer Biomaker Market ... ResearchMoz presents this most up-to-date research ... 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion ... Analysis. GLOBAL & USA ...
(Date:7/19/2014)... United States Non-Vascular Stents Market Outlook ... "United States Non-Vascular Stents Market Outlook to 2020", ... Non-Vascular Stents market. The report provides value, in ... average prices (in US dollars) within market segments ... Biliary Stents (Metal Non-Covered Biliary Stents, Metal Partially ...
(Date:7/18/2014)... is mostly neutral. That is, most of the ... number of electrons in the outer parts of atoms ... atoms. As one or more electrons are plucked ... much stronger positive pull from the nucleus. This ... ensures that those electrons are less vulnerable to the ...
(Date:7/18/2014)... Emerging Nuclear Power Countries - Market Forecast, Key ... The latest report from GlobalData, Emerging Nuclear Power Countries ... 2030 covers the emerging nuclear market and the key ... key market players and their global market share. The ... the world has also been estimated. , To browse ...
Breaking Biology Technology:Global & USA Cancer Biomaker Market to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-Development, Business Strategies, Industry Trends, and Pipeline Analysis) - Market Size, Trends, and Forecasts A 2Global & USA Cancer Biomaker Market to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-Development, Business Strategies, Industry Trends, and Pipeline Analysis) - Market Size, Trends, and Forecasts A 3Global & USA Cancer Biomaker Market to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-Development, Business Strategies, Industry Trends, and Pipeline Analysis) - Market Size, Trends, and Forecasts A 4Global & USA Cancer Biomaker Market to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-Development, Business Strategies, Industry Trends, and Pipeline Analysis) - Market Size, Trends, and Forecasts A 5Global & USA Cancer Biomaker Market to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-Development, Business Strategies, Industry Trends, and Pipeline Analysis) - Market Size, Trends, and Forecasts A 6United States Non-Vascular Stents Market Outlook to 2020 | Researchmoz 2United States Non-Vascular Stents Market Outlook to 2020 | Researchmoz 3United States Non-Vascular Stents Market Outlook to 2020 | Researchmoz 4Highly charged ions 2Highly charged ions 3Highly charged ions 4Emerging Nuclear Power Countries - Market Forecast, Key Companies and Development Analysis, Size, Share, Growth, Trend to 2030 2Emerging Nuclear Power Countries - Market Forecast, Key Companies and Development Analysis, Size, Share, Growth, Trend to 2030 3
... 17 Repligen Corporation,(Nasdaq: RGEN ) announced today ... Herlihy, Ph.D., will present at the 2008 UBS,Global Life ... EDT at the Grand Hyatt Hotel, 455 Madison Avenue, ... presentation will be available via,Repligen,s website at http://www.repligen.com ...
... 17 /PRNewswire-FirstCall/ - AEterna Zentaris Inc.,(NASDAQ: AEZS ... on,endocrine therapy and oncology, today announced that its ... CA, will present a,company overview at the upcoming ... Tuesday, September 23, 2008 at 3:25 pm (eastern,time), ...
... Coast Oncology to be the first private practice in ... offer state-of-the-art proton radiation ... M.D.,Medical Director, First Coast Oncology, Jacksonville, FL is pleased ... Monarch250(TM),Proton Therapy System from Still River Systems, Inc, in ...
Cached Biology Technology:Repligen to Present at the 2008 UBS Global Life Sciences Conference Wednesday, September 24th, 1:00 p.m. EDT 2Repligen to Present at the 2008 UBS Global Life Sciences Conference Wednesday, September 24th, 1:00 p.m. EDT 3First Coast Oncology to Offer Next Generation Proton Therapy 2First Coast Oncology to Offer Next Generation Proton Therapy 3
(Date:7/21/2014)... hotspots in areas across Riau province on Sunday, July ... following a decline in rainfall. The number of ... what had been reported one day prior, which had ... in six regencies and municipalities, most of which were ... haze it creates could potentially spread via winds to ...
(Date:7/21/2014)... to climate change, due to greenhouse gasses emitted by ... the rise and that beef cattle are responsible for ... animals. It is published by Climactic Change . ... it comes to climate change. It is released by ... portion of greenhouse gas totals. But methane and nitrous ...
(Date:7/21/2014)... causing problems for the world,s water sources. In ... stormwater runoff to be one of the top ... lakes, ponds, reservoirs, bays, and estuaries. The pollutants ... wildlife populations, foul drinking water, and make recreational ... University are looking to rain gardens as one ...
Breaking Biology News(10 mins):Climate: Meat turns up the heat 2Filter bed substrates, plant types recommended for rain gardens 2
... plants ship sugars from their leaves to flowers, roots, ... engineering techniques, Cornell researchers have finally proven a long-standing ... deepen understanding of basic plant biology but could one ... photosynthetic rates, yields and carbon dioxide intake. This might ...
... to better understand the relationship between the bacteria ... defense cells that engulf them., The researchers have ... tuberculosis does not react when immune system ... bacterium,s genes become activated minutes after the pathogen ...
... winners of its student travel award to attend the ... Biophysics Congress in Long Beach, California, February 2-6, 2008. ... on scientific merit, with priority given to those who ... awardee receives a travel grant and will be recognized ...
Cached Biology News:Cornell researchers prove how plants transport sugars 2Cornell researcher seeks clues to how tuberculosis infects cells 2Biophysical Society announces winners of 2008 Student Travel Awards 2Biophysical Society announces winners of 2008 Student Travel Awards 3Biophysical Society announces winners of 2008 Student Travel Awards 4Biophysical Society announces winners of 2008 Student Travel Awards 5
... The thermostable dUTPase(pyrococcus fruriosus) maximizes the ... DNA polymerases). It removes contaminating ... dNTP solutions. The presence of ... reaction can prevent dUTP misincorporation by ...
... comes with a shutter (controlled via a TTL ... Deuterium Light Source produces a powerful, stable output ... the light source are available, providing a wavelength ... lamp provides peak-to-peak stability of less than 0.005% ...
... The NOVOstar is an exciting product for ... cell-based assays required the use of expensive ... for scientists in the assay development stage. ... for cell-based assays as well as any ...
... intactness and detects events that dissipate ... Benefits: Fast, simple, and ... and for assaying mitochondria intactness ... for the detection of changes in ...
Biology Products: